Progress in the treatment of hyperphosphatemia in patients with chronic kidney disease
10.3760/cma.j.issn.1008-6706.2020.11.030
- VernacularTitle:慢性肾脏病患者高磷血症治疗进展
- Author:
Weinan XIE
1
;
Zhi LIU
Author Information
1. 蚌埠医学院研究生院 233000
- From:
Chinese Journal of Primary Medicine and Pharmacy
2020;27(11):1405-1408
- CountryChina
- Language:Chinese
-
Abstract:
Chronic kidney disease (CKD) is one of the most urgent problems in global health since its discovery, which is characterized by high prevalence rate, multiple complications and poor long-term prognosis.And hyperphosphatemia, which has not been overcome clinically, is the most common complications of CKD.Keeping blood phosphorus concentrations within a normal range is extremely important for CKD patients, which not only effectively improves their prognosis, but also extends their lifespan.This article will briefly review the progress in the treatment of hyperphosphatemia from the aspects of dietary control, replacement of phosphorus-containing drugs, comparison of phosphorus binders, excretion of urinary phosphorus, and intensification of dialysis and traditional Chinese medicine.
